Precision Medicine With Zibotentan in Microvascular Angina

PHASE2CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
Microvascular Angina
Interventions
DRUG

Zibotentan

10mg OD Zibotentan

DRUG

Placebo oral tablet

Placebo

Trial Locations (1)

Unknown

NHS Greater Glasgow and Clyde, Glasgow

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Glasgow

OTHER

collaborator

King's College London

OTHER

collaborator

University of Oxford

OTHER

collaborator

Oxford University Hospitals NHS Trust

OTHER

collaborator

University of Cambridge

OTHER

collaborator

Papworth Hospital NHS Foundation Trust

OTHER_GOV

collaborator

Blackpool Teaching Hospitals NHS Foundation Trust

OTHER

collaborator

Royal Free Hospital NHS Foundation Trust

OTHER

collaborator

AstraZeneca

INDUSTRY

collaborator

Siemens Healthcare Ltd

UNKNOWN

lead

NHS Greater Glasgow and Clyde

OTHER